Medical Device | Healthcare | Biotechnology | Pharmaceuticals

The global PCR technologies market is poised to witness an increasing demand growth during the forecast period. This is expected to be driven by major factors such as expansion in its application areas and procedural benefits offered by PCR technologies (such as real-time process monitoring, low reagent consumption, and device miniaturization, among others), increasing investments in gene therapy and government support for product R&D, rise in number of diagnostic centers & hospitals, and increasing investments and availability of funds for PCR-based research. Modernization and miniaturization of the polymerase chain reaction process are offering high growth opportunities for players active in the global PCR technologies market. However, unfavorable reimbursement scenario, lack of technically skilled professionals, and high cost of dPCR devices and are some of the key factors hampering the growth of this market during the forecast period. Download PDF Brochure: https://www

Major players profiled in the global knee reconstruction equipment market report include Zimmer, Inc. (U.S.), Stryker (U.S.), DePuy Synthes (U.S.), Smith & Nephew plc (U.K.), Arthrex, Inc. (U.S.), Exactech, Inc. (U.S.), Corin (U.K.), DJO Global (U.S.), Japan Medical Dynamic Marketing, Inc. (Japan), Tornier, Inc. (Netherlands), and United Orthopedic Corporation (Taiwan), among others. Key stakeholders of knee reconstruction equipment market include orthopedic implant manufacturing companies, distributors of medical devices, healthcare institutions (hospitals, medical schools, and governing bodies), health insurance players, research and consulting firms, and regulatory authorities such as Food and Drug Administration (FDA). Technological advancements in the global knee reconstruction equipment market, such as newly developed prostheses with improved strength and reliability of joints, are reducing the need and cost of revision surgeries. Additionally, the rising healthcare ex

Medtronic (Ireland), B. Braun (Germany), Dexcom (US), Abbott Laboratories (US), Roche Diagnostics (Switzerland), Insulet Corporation (US), Tandem Diabetes Care (US), Ascensia Diabetes Care (Switzerland), LifeScan (US), Tidepool (US), AgaMatrix (US), Glooko Inc. (US), and DarioHealth (Israel) are the leading players in this market. These companies are focusing on increasing their presence in the high-growth markets through both organic as well as inorganic growth strategies such as product launches, approvals, and enhancements; expansions; agreements, collaborations, and partnerships; and mergers & acquisitions. The global  digital diabetes management market  is projected to reach USD 19.9 billion by 2024 from USD 6.8 billion in 2019, at a CAGR of 23.8%. Factors such as the rising prevalence of diabetes, technological advancements, increasing adoption of cloud-based enterprise solutions, and the growing use of connected devices and apps are driving the growth of this market. Howeve

Key players in the global epigenetics market , such as Illumina, Thermo Fisher, Diagenode, Merck Millipore, Abcam, Active Motif, New England Biolabs, Agilent, Zymo Research, and PerkinElmer, are focusing on increasing their presence in the high-growth markets through organic as well as inorganic strategies such as product launches, partnerships, agreements, collaborations, expansions, and acquisitions. The growth in epigenetics market is primarily attributed to decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases. Expanding application areas of epigenetics in non-oncology diseases, personalized medicine, and target therapy are expected to provide growth opportunities for players operating in the in the coming years. According to a press release published by the Tufts Center for the Study of Drug Development in May 2015, biopharmaceutical companies h

The global hybrid operating room market is expected to grow at a CAGR of 12.5% between 2017 and 2022. Factors driving the growth of this market include the increasing adoption of minimally invasive surgical procedures and technological advancements among others. As of 2016, Philips Healthcare (The Netherlands), Siemens Healthineers (Germany), Stryker Corporation (U.S.), Toshiba Corporation (Japan), GE Healthcare (U.S.), IMRIS Inc. (U.S.), Eschmann Equipment (U.K.), MAQUET GmbH (Germany), Trumpf Medical (Germany), and Skytron LLC (U.S.), Richard Wolf GmbH (Germany), MIZUHO OSI (U.S.), STERIS plc. (U.S.), NDS Surgical Imaging (U.S.), Alvo (Poland) are some of the major manufacturers in hybrid operating room market . Analysis of the market developments between 2014 and 2017 (March) show that new product launch, agreements, and collaborations were the most widely adopted growth strategies by players in the market. Players adopted these strategies to strengthen their market positio

The global ostomy care accessories market is estimated to be valued at USD 2.40 Billion in 2017 and is projected to reach USD 2.99 Billion by 2022, growing at a CAGR of 4.5%. The high incidence of bladder/colorectal cancer/inflammatory bowel disease; rising geriatric population; growing number of awareness programs to educate patients regarding the use of ostomy products; technological advancements in ostomy products; and efficient reimbursement system in developed countries are factors driving the growth of the ostomy care market. Analysis of the ostomy care accessories market developments between 2015 and 2017 revealed that several growth strategies such as product launches and product enhancements, strategic acquisitions, agreements, contracts, and market expansions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the ostomy care market. Among these business strategies, product launches and product enhancements were t

The global  healthcare consulting services market  is expected to reach USD 15.88 billion by 2023 from USD 9.76 billion in 2018 at a CAGR of 10.2%. Market growth is primarily driven by the growing geriatric population, the rising importance of value-based care; and technological advancements in healthcare. This report broadly segments the healthcare consulting services market by the type of service, end user, and region. The report also contains information on market share analysis and growth opportunities in the healthcare consulting services market in various regions. By type of service, the healthcare consulting services market is segmented into digital consulting, IT consulting, operations consulting, financial consulting, strategy consulting, and HR & talent consulting. The digital consulting segment accounted for the largest share of the healthcare consulting services market in 2017. Factors driving the growth of this segment include the shift from paper-based healthcar

The global  urology surgical instruments market  is expected to reach USD 11.48 Billion by 2021 from USD 7.74 Billion in 2016, growing at a CAGR of 8.2% from 2016 to 2021. The growth of the overall urology surgical instruments market can be contributed to rising prevalence of kidney diseases and urinary tract infections; rising number of hospitals and growing hospital investments in surgical infrastructure; availability of investments, funds, and grants from government bodies; and rising geriatric population. n this report, the urology surgical instruments market has been segmented on the basis of product, and application. On the basis of product, the urology surgical instruments market is categorized into urology endoscopes, endovision systems, peripheral instruments, and consumables and accessories. The increasing number of conferences further assist the growth of the APAC urology surgical instrument industry. Conference Series LLC company organizes conferences for various comp

The  laboratory mixer market  is expected to grow from USD 1.1 billion in 2018 to USD 1.4 billion by 2023, at a CAGR of 4.4% during the forecast period. Increasing research activity in the pharmaceutical and biotechnology industries is the major factor driving the growth of this market. However, the high cost of advanced laboratory mixers and long equipment lifespans are expected to restrain the growth of this market during the forecast period. The magnetic stirrers segment is projected to grow at the highest CAGR between 2018 and 2023. Magnetic stirrers are most commonly used in chemical and biological research laboratories to ensure that liquid samples are homogeneous in consistency and temperature. The growth of this segment can be attributed to the growth in funding for life science research and the increasing number of research laboratories The laboratory mixer market is divided into four major regions—North America, Europe, Asia Pacific, and the Rest of the World (RoW). In

The global  bariatric surgery devices market  was valued at USD 1.51 Billion in 2017 and is projected to reach USD 2.16 Billion by 2023, at a CAGR of 5.7% during the forecast period. Base year considered for the report is 2017 and the forecast period is 2018–2023. Objectives of the Study : To define, describe, and forecast the global bariatric surgery devices market by type, procedure, and region To provide detailed information regarding factors influencing market growth (drivers, restraints, opportunities, and challenges) To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market To analyze market opportunities for stakeholders and provide details of the competitive landscape of market leaders To forecast the size of the bariatric surgery devices market in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa To profile the key players in the global market and comprehensiv

The global  hydrophobic interaction chromatography market  is projected to reach USD 418.2 million in 2023 from USD 271.0 million in 2017, at a CAGR of 7.5%. The base year considered for the study is 2017, and the forecast for the market size is provided for the period between 2018 and 2023. In the current market scenario, there is a growing demand for hydrophobic interaction chromatography. The major factors driving the growth of this market are the increasing demand for monoclonal antibodies and increasing R&D expenditure in biopharmaceuticals. Market Dynamics Drivers Increasing demand for monoclonal antibodies Increasing R&D expenditure in biopharmaceuticals Opportunities Increasing number of CMOs and CROs Patent Expiry Challenges Lack of skilled professionals and highly qualified researchers Monoclonal antibodies likely to drive the market In the past decade, there has been a significant increase in the demand for mAbs not only in oncology but sever